COVID 19 News and Research

RSS

Study reveals: Coronaviruses that cause common colds boost immune response to COVID-19

During the pandemic, it became clear that children who contracted COVID-19 became less ill than adults. One hypothesis has been that common colds would give children immunity protecting against a severe form of the disease. Researchers at Karolinska Institutet are now able to show that OC43, one of the coronaviruses that cause common colds, boosts the immune response to COVID-19. The study, which is published in PNAS, could give rise to more tailored vaccine programmes for children and adults.

16 Mar 2023

Age-related sarcopenia prevented by AAV1.NT-3 gene therapy

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 5, entitled, "AAV1.NT-3 gene therapy prevents age-related sarcopenia."

16 Mar 2023

New framework to identify possible viral hazards to human health

The majority of what scientists know about viruses in animals comes from the list of nucleotides that constitute their genomic sequence, which, although useful, provides relatively few signals about a virus’ propensity to infect people.

14 Mar 2023

Novel technology easily detects active Mycobacterium tuberculosis infection antibodies

A team of faculty from Wayne State University has discovered new technology that will quickly and easily detect active Mycobacterium tuberculosis (TB) infection antibodies.

14 Mar 2023

New class of oral drugs inhibits a diverse range of SARS-CoV-2 strains

The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their arsenal for treating drug-resistant infections. Researchers have now discovered that a new class of oral drugs that acts directly on human cells can inhibit a diverse range of pathogenic SARS-CoV-2 strains.

13 Mar 2023

COVID-19 has taken a limited toll on the mental health, finds study

COVID-19 has taken a relatively limited toll on the mental health of most people around the globe, according to a paper published today in the BMJ by a McGill University-led research team involving collaborators from McMaster University, the University of Toronto, and other institutions.

10 Mar 2023

BGI’s fluorescent RT-PCR kit obtains market access qualification for detecting SARS-CoV-2, IFV A, IFV B in Australia

On March 2, BGI's Multiplex Real-time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2, Influenza A Virus and Influenza B Virus obtained market access qualification to enter the Australian Register of Therapeutic Goods.

8 Mar 2023

Largest-ever genetic analysis provides insight into domestications and origin of traits in grapevine

In the largest ever genetic analysis of grapevine varieties, including samples from previously undocumented specimens in private collections, researchers provide new insights into how, when, and where wine and table grapevines were domesticated, which has been a longstanding question.

3 Mar 2023

New method can rapidly detect COVID-19 infections with near-perfect accuracy

By inspecting the body's immune response at a molecular level, a research team has developed a new way to test patients for COVID-19.

28 Feb 2023

Effective and faster methodology detects RNA viruses based on the triplex-forming probe technology

Experts from the University of Barcelona, the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), the Institute of Microelectronics of Barcelona (IMB-CNM-CSIC) and the Aragon Nanoscience and Materials Institute of Aragon (INMA) -;a joint institute of the CSIC and the University of Zaragoza-; have developed a new method to detect RNA viruses based on the triplex-forming probe technology.

28 Feb 2023

Insilico Medicine: IND application for first generative AI-designed drug for COVID-19 approved

Insilico Medicine, a clinical-stage biotech company powered by generative AI, today announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for ISM3312, an orally available 3CLpro inhibitor generated and designed with the support of Insilico's proprietary generative chemistry platform Chemistry42 for the treatment of COVID-19.

24 Feb 2023

Study uncovers differences in how AstraZeneca and Pfizer COVID-19 vaccines affect the immune system

A new Australian study led by SAHMRI and Flinders University has uncovered fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system.

23 Feb 2023

MIT engineers develop new procedure to 3D print a soft, flexible replica of patient's heart

No two hearts beat alike. The size and shape of the the heart can vary from one person to the next. These differences can be particularly pronounced for people living with heart disease, as their hearts and major vessels work harder to overcome any compromised function.

23 Feb 2023

New puzzle challenge taps into the intelligence of Eterna’s users to advance RNA therapeutics

Researchers at UC Santa Cruz working to develop novel RNA-based medicines are teaming up with a new group of collaborators-;players of the online game Eterna.

22 Feb 2023

Study shows how convalescent plasma can be used as effective treatment during future pandemics

Three years into the COVID-19 pandemic, new variant outbreaks continue to fuel economic disruptions and hospitalizations across the globe.

22 Feb 2023

Exploring the benefits of urban sheep grazing

Bicycles whirr by, students rush to class, staff and faculty are grabbing lunch or coffee on the go -; and sheep graze the grassy knolls among the traffic, bleating every now and then. The grazing is their job.

22 Feb 2023

Pets help improve the mental health and wellbeing of older people

Furry, finned, or feathered, our family pets come in all shapes and sizes. But while these friendly faces keep us company at home, it's a very different story for people in aged care – many of whom must relinquish their beloved pet as a condition of entry.

21 Feb 2023

Novel molecule prevents cells from infection with SARS-COV-2

The virus that causes COVID-19, called SARS-CoV-2, uses its spike protein in order to stick to and infect our cells. The final step for the virus to enter our cells is for part of its spike protein to act like a twist tie, forcing the host cell's outer membrane to fuse with the virus.

20 Feb 2023

Expert releases open-source compilation of the SARS-CoV-2 molecular structure

A biomedical researcher at the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, has created a groundbreaking resource for scientists seeking to develop new and better vaccines in the fight against COVID-19.

19 Feb 2023

Researchers reveal link immune system genetics and a person's ability to resist new COVID-19 variants

An international team including researchers from the HSE University Faculty of Biology and Biotechnology has found a link between certain genetic features of the immune system and one's ability to effectively resist new waves of COVID-19.

17 Feb 2023

COVID 19 News and Research

Study reveals: Coronaviruses that cause common colds boost immune response to COVID-19

Age-related sarcopenia prevented by AAV1.NT-3 gene therapy

New framework to identify possible viral hazards to human health

Novel technology easily detects active Mycobacterium tuberculosis infection antibodies

New class of oral drugs inhibits a diverse range of SARS-CoV-2 strains

COVID-19 has taken a limited toll on the mental health, finds study

BGI’s fluorescent RT-PCR kit obtains market access qualification for detecting SARS-CoV-2, IFV A, IFV B in Australia

Largest-ever genetic analysis provides insight into domestications and origin of traits in grapevine

New method can rapidly detect COVID-19 infections with near-perfect accuracy

Effective and faster methodology detects RNA viruses based on the triplex-forming probe technology

Insilico Medicine: IND application for first generative AI-designed drug for COVID-19 approved

Study uncovers differences in how AstraZeneca and Pfizer COVID-19 vaccines affect the immune system

MIT engineers develop new procedure to 3D print a soft, flexible replica of patient's heart

New puzzle challenge taps into the intelligence of Eterna’s users to advance RNA therapeutics

Study shows how convalescent plasma can be used as effective treatment during future pandemics

Exploring the benefits of urban sheep grazing

Pets help improve the mental health and wellbeing of older people

Novel molecule prevents cells from infection with SARS-COV-2

Expert releases open-source compilation of the SARS-CoV-2 molecular structure

Researchers reveal link immune system genetics and a person's ability to resist new COVID-19 variants

The Last Piece of Our Genome: Sequencing the Y Chromosome

Understanding the Importance of Entrepreneurship in the Life Sciences Community

Supporting Informed Decisions on Malaria Biocontrol Interventions

Latest in Genomics